Nemaura Medical Inc.
Index- P/E- EPS (ttm)-0.54 Insider Own49.40% Shs Outstand23.31M Perf Week-12.84%
Market Cap60.21M Forward P/E- EPS next Y-0.51 Insider Trans0.00% Shs Float9.95M Perf Month-36.91%
Income-12.40M PEG- EPS next Q-0.14 Inst Own2.20% Short Float1.41% Perf Quarter-42.63%
Sales0.20M P/S301.07 EPS this Y-40.50% Inst Trans- Short Ratio15.08 Perf Half Y-51.81%
Book/sh0.04 P/B63.25 EPS next Y8.80% ROA-38.30% Target Price12.17 Perf Year-80.31%
Cash/sh0.97 P/C2.62 EPS next 5Y- ROE-228.40% 52W Range2.15 - 17.40 Perf YTD-44.52%
Dividend- P/FCF- EPS past 5Y-29.80% ROI- 52W High-85.46% Beta0.22
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin6.10% 52W Low17.67% ATR0.29
Employees25 Current Ratio1.60 Sales Q/Q- Oper. Margin- RSI (14)29.02 Volatility14.70% 10.07%
OptionableYes Debt/Eq23.60 EPS Q/Q-133.20% Profit Margin- Rel Volume1.57 Prev Close2.66
ShortableYes LT Debt/Eq8.70 Earnings- Payout- Avg Volume9.28K Price2.53
Recom2.00 SMA20-24.64% SMA50-33.63% SMA200-49.36% Volume14,406 Change-4.89%
Mar-29-22Initiated H.C. Wainwright Buy $12
May-19-22 08:00AM  
May-17-22 08:00AM  
May-03-22 08:00AM  
Apr-27-22 09:00AM  
Apr-25-22 08:30AM  
Mar-24-22 04:24PM  
Feb-28-22 08:00AM  
Feb-14-22 08:00AM  
Jan-13-22 08:30AM  
Jan-10-22 08:00AM  
Jan-07-22 08:00AM  
Dec-07-21 09:00AM  
Nov-30-21 08:00AM  
Nov-15-21 09:30AM  
Nov-03-21 06:51PM  
Oct-25-21 01:02PM  
Oct-19-21 12:45PM  
Oct-06-21 12:05PM  
Oct-05-21 08:00AM  
Sep-29-21 11:17AM  
Sep-28-21 01:50PM  
Sep-27-21 08:00AM  
Sep-24-21 08:30AM  
Sep-22-21 08:30AM  
Sep-21-21 08:30AM  
Sep-20-21 10:51AM  
Sep-17-21 09:05AM  
Sep-01-21 08:00AM  
Aug-16-21 08:30AM  
Jul-26-21 07:08AM  
Jul-12-21 08:28AM  
Jul-08-21 11:20AM  
Jun-30-21 09:15AM  
Jun-21-21 08:01AM  
Jun-01-21 08:05AM  
May-27-21 07:15PM  
May-26-21 08:05AM  
May-06-21 08:00AM  
May-05-21 08:00AM  
May-04-21 04:10PM  
Apr-29-21 08:04AM  
Apr-21-21 08:10AM  
Apr-15-21 08:07AM  
Apr-13-21 08:05AM  
Mar-25-21 08:10AM  
Mar-11-21 08:00AM  
Mar-10-21 08:00AM  
Mar-04-21 08:00AM  
Mar-02-21 08:00AM  
Feb-16-21 08:30AM  
Feb-11-21 08:45AM  
Feb-08-21 02:57AM  
Feb-04-21 08:30AM  
Feb-01-21 08:00AM  
Jan-25-21 05:11AM  
Jan-11-21 08:00AM  
Dec-17-20 08:00AM  
Dec-11-20 09:00AM  
Nov-17-20 08:00AM  
Nov-16-20 08:00AM  
Oct-22-20 08:00AM  
Sep-21-20 08:00AM  
Sep-18-20 11:11AM  
Sep-03-20 06:00AM  
Aug-31-20 05:00PM  
Aug-25-20 07:38AM  
Aug-19-20 07:00AM  
Aug-17-20 06:59AM  
Aug-06-20 01:43PM  
Jul-28-20 08:03AM  
Jul-27-20 07:17PM  
Jul-23-20 07:19AM  
Jul-14-20 07:03AM  
Jul-07-20 06:00AM  
Jun-30-20 06:59AM  
Jun-26-20 07:04AM  
Jun-23-20 08:20AM  
Jun-16-20 06:45AM  
Jun-10-20 07:00AM  
Jun-09-20 08:30AM  
May-20-20 07:00AM  
May-11-20 06:04AM  
May-05-20 09:18AM  
Apr-21-20 07:21AM  
Apr-01-20 08:03AM  
Mar-30-20 04:06PM  
Mar-20-20 04:39PM  
Mar-18-20 07:00AM  
Mar-10-20 07:00AM  
Mar-03-20 07:00AM  
Feb-25-20 09:17AM  
Feb-11-20 09:00AM  
Dec-20-19 09:00AM  
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.